PHE_Scientific - Spike RBD Antibody SARS-CoV-2 (2019-nCoV)
Public Health England (PHE) has awarded a contract to Stratech Scientific Ltd for the provision of Spike RBD Antibody SARS-CoV-2 . This urgent requirement is in response to the COVID -19 outbreak.
Buyer
Public Health England
Value
£12,000
Published
3 Feb 2021
Closes
10 Nov 2020
Procurement details
Source
Contracts Finder
Region
United Kingdom
Procurement method
Direct
Category
Goods
Contract starts
11 Nov 2020
Contract ends
10 Nov 2021
CPV classifications
33141500
Haematological consumables
Lots
Lot default PHE_Scientific - Spike RBD Antibody SARS-CoV-2 (2019-nCoV)
£12,000
Public Health England (PHE) has awarded a contract to Stratech Scientific Ltd for the provision of Spike RBD Antibody SARS-CoV-2 . This urgent requirement is in response to the COVID -19 outbreak.
Delivery: British Oversea Territories, Channel Islands, Europe, Isle of Man, Rest of the World, United Kingdom
Documents
Unlock document linkAwarded contract notice on Contracts Finder
3 Feb 2021
Awarded contract notice on Contracts Finder
Award notice · Web page
Contains public sector information licensed under the Open Government Licence v3.0.